...
首页> 外文期刊>Acta biomaterialia >Elastin-like recombinamer-covered stents: Towards a fully biocompatible and non-thrombogenic device for cardiovascular diseases
【24h】

Elastin-like recombinamer-covered stents: Towards a fully biocompatible and non-thrombogenic device for cardiovascular diseases

机译:类弹性蛋白覆盖的覆膜支架:朝着完全生物相容且无血栓形成的心血管疾病装置发展

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We explored the use of recently developed gels obtained by the catalyst free click reaction of elastin-like recombinamers (ELRs) to fabricate a new class of covered stents. The approach consists in embedding bare metal stents in the ELR gels by injection molding, followed by endothelialization under dynamic pressure and flow conditions in a bioreactor. The mechanical properties of the gels could be easily tuned by choosing the adequate concentration of the ELR components and their biofunctionality could be tailored by inserting specific sequences (RGD and REDV). The ELR-covered stents exhibited mechanical stability under high flow conditions and could undergo crimping and deployment without damage. The presence of RGD in the ELR used to cover the stent supported full endothelialization in less than 2 weeks in vitro. Minimal platelet adhesion and fibrin adsorption were detected after exposure to blood, as shown by immunostaining and scanning electron microscopy. These results prove the potential of this approach towards a new and more effective generation of covered stents which exclude the atherosclerotic plaque from the blood stream and have high biocompatibility, physiological hemocompatibility and reduced response of the immune system. (C) 2014 Acts Materialia Inc. Published by Elsevier Ltd. All rights reserved.
机译:我们探索了通过弹性蛋白样重组子(ELR)的无催化剂点击反应获得的最近开发的凝胶的用途,以制造一类新型的覆膜支架。该方法包括通过注塑将裸金属支架嵌入ELR凝胶中,然后在生物反应器中在动态压力和流动条件下进行内皮化。可以通过选择适当浓度的ELR组分轻松调节凝胶的机械性能,并可以通过插入特定序列(RGD和REDV)来调整其生物功能。被ELR覆盖的支架在高流量条件下表现出机械稳定性,并且可以进行压接和展开而不会造成损坏。用于覆盖支架的ELR中RGD的存在在不到2周的时间内支持了完全内皮化。免疫染色和扫描电子显微镜显示,暴露于血液后,血小板粘附和纤维蛋白的吸附最小。这些结果证明了这种方法对于新一代和更有效的覆盖支架的潜力,该覆盖支架从血流中排除了动脉粥样硬化斑块,并且具有高生物相容性,生理血液相容性和免疫系统应答降低。 (C)2014 Acts Materialia Inc.,由Elsevier Ltd.发行。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号